A 'mix and match' approach to SARS-CoV-2 vaccination
Nat Med
.
2021 Sep;27(9):1510-1511.
doi: 10.1038/s41591-021-01463-x.
Authors
Meagan E Deming
1
,
Kirsten E Lyke
2
Affiliations
1
The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
2
The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. klyke@som.umaryland.edu.
PMID:
34312555
DOI:
10.1038/s41591-021-01463-x
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2*
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
UM1 AI148684/AI/NIAID NIH HHS/United States